Treatment Advances

Our Treatment Advances articles cover treatment option updates, new combinations of treatments, FDA approval news, and more.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

What Mobilizing Agents Are and What They Mean for Your Stem Cell Collection

February 20, 2025

Motixafortide has shown promise in increasing the amount of stem cells that myeloma patients can collect in one sitting.

Is It Time to Reduce Dex Dosages for Myeloma Patients?

February 11, 2025

Learn what it would take for the standard of care dexamethasone dose to change when treating myeloma.

New Biomaterial Shows Promise for Bone Healing in Myeloma Patients

February 03, 2025

A new biomaterial, a silica-collagen xerogel, is being tested in combination with bortezomib to heal bone lesions caused by myeloma.

FDA Reviews Belantamab Mafodotin for Approval in Relapsed/Refractory Multiple Myeloma

December 05, 2024

FDA reviews belantamab mafodotin for relapsed multiple myeloma, the decision is expected by July 2025.

BRCA Gene Testing in Multiple Myeloma: New Research Reveals Treatment Insights

November 28, 2024

Learn how BRCA gene mutations affect myeloma risk. Learn why genetic testing could be crucial for younger patients and those with family cancer history.

Myeloma Treatments that Target the Microenvironment

November 14, 2024

Learn about the microenvironment and how certain treatments target myeloma cells' interaction with the cells around them.

New Treatment Coming for High-Risk Smoldering Myeloma?

November 12, 2024

Johnson & Johnson seeks FDA and EMA approval for Darzalex Faspro in high-risk smoldering myeloma, aiming to change the treatment paradigms.

How Myeloma Induction Therapy Is Evolving: Vital Insights for Newly Diagnosed Patients

November 07, 2024

Learn what newly diagnosed multiple myeloma patients need to know about how induction (starting) therapy is evolving in the myeloma treatment landscape.

Taking a Break from Lenalidomide Maintenance

October 18, 2024

Learn what two recent studies have to say about who could possibly come off their maintenance therapy and for how long they could stay off.

Managing MGUS and Smoldering Myeloma: Current Strategies and Future Directions

October 17, 2024

Learn how findings from the International Myeloma Society 2024 meeting highlight the challenges and future consideration of MGUS and smoldering myeloma.